Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Consumerlab.com book

This article was originally published in The Tan Sheet

Executive Summary

Consumerlab.com's Guide to Buying Vitamins & Supplements: What's Really in the Bottle? will debut at Natural Products Expo East in Washington D.C Sept. 4-7. Book "exposes problems found with supplements, identifies products shown to be best and offers new tips on how to buy and use supplements," co-author and firm President Tod Cooperman, MD, explains. Publication of the guide has been delayed twice; it was to be released in late summer 2002 originally (1"The Tan Sheet" May 20, 2002, p. 19)...

You may also be interested in...



Magnesium Supplements Exceeding Tolerable UL Clear ConsumerLab Tests

Eleven of 19 magnesium and magnesium/calcium dietary supplements reviewed by ConsumerLab.com contained magnesium amounts in excess of the Tolerable Upper Intake Level (UL) for the mineral

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095707

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel